Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.6M | $7.7M | $7.4M | $8.3M | $7.8M | $25.0M | $6.3M | $5.6M | $5.0M | $6.3M | $4.2M | $2.2M | $1.2M | $564,142 | $208,399 | $357,167 |
| Gross profit | $3.1M | $3.6M | $4.3M | $5.1M | $4.6M | $15.0M | $3.9M | $3.1M | $3.1M | $3.7M | $2.5M | $1.4M | $685,779 | $222,012 | $71,240 | $211,871 |
| Research & development | $289,899 | $290,683 | $491,798 | $352,238 | $572,700 | $455,046 | $340,582 | $916,003 | $454,089 | $184,259 | $100,321 | $155,984 | $127,547 | $2,384 | — | — |
| Operating expenses | $6.9M | $7.7M | $7.6M | $7.9M | $9.5M | $10.5M | — | — | — | — | — | — | — | — | — | — |
| Operating income | −$3.9M | −$4.1M | −$3.3M | −$2.9M | −$4.9M | $4.5M | −$2.1M | −$3.1M | −$3.4M | −$3.4M | −$3.0M | — | — | — | — | — |
| EBITDAderived | −$3.6M | −$3.8M | −$3.0M | −$2.6M | −$4.6M | $5.2M | −$1.4M | −$2.4M | −$2.8M | −$2.8M | −$2.5M | — | — | — | — | — |
| Net income | −$3.7M | −$4.5M | −$3.4M | −$2.9M | −$4.4M | $4.4M | −$2.3M | −$3.2M | −$3.6M | −$3.2M | −$12.2M | $268,436 | −$5.7M | −$1.8M | −$824,880 | −$1.5M |
| Basic EPSper diluted share | -$0.19 | -$0.22 | -$0.17 | -$0.15 | -$0.25 | $0.27 | -$0.15 | -$0.03 | -$0.03 | -$0.03 | -$0.12 | $0.00 | -$0.07 | -$0.02 | — | — |
| Diluted EPSper diluted share | -$0.19 | -$0.22 | -$0.17 | -$0.15 | -$0.25 | $0.23 | -$0.15 | -$0.03 | -$0.03 | -$0.03 | -$0.12 | $0.00 | -$0.07 | — | — | — |